Feasibility of Web-based Therapy Sessions
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLiverpool University Hospitals NHS Foundation Trust
About this trial
The goal of this feasibility study is to explore rehabilitation outcomes, usability and user experience of a web-based platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders in critical illness and stroke disorders.
The main question it aims to answer is:
" Is it feasible to use a web-based platform for delivering rehabilitation treatment in a large acute National Health Care Organisation"
Participants will undergo therapy sessions prescribed by therapists on a web-based platform instead of the conventional paper-based therapy sessions for their cognitive and speech rehabilitation needs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with cognitive impairment and/or speech impairment being treated at the LUHFT Intensive Care Units and the Stroke wards
Need for Cognitive and/or speech and Language rehabilitation
Disqualifiers
Inability to obtain consent
Refusal to take part in the study
Failure to engage with the Cognishine platform
Inability to operate a mobile device/ tablet with support
Trial design
Design model
Single group
Treatments tested in this trial
a Web-Based Platform for delivering treatment for cognitive and language impairment amongst adults with acquired neurological disorders
BehavioralThe Cognishine platform is a digital (web-based) general health and wellness monitoring platform. It is designed to support health care professionals specialised in rehabilitation of patients with neurological disorders, through a wide range of multi-media based generalised activities across speech, language, social-emotional, and cognition.
Treatment groups
80 Participants
are divided into 1 treatment groupGroup A: Web-based patient-led therapy sessionsExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
To assess the feasibility of using the Cognishine web-based platform in a large NHS Trust in acute care setting.
Total number of completed sessions per patient on the cognishine platform
Time frame
From recruitment until discharge from rehabilitation therapy or discharge from hospital, which ever comes first. Time frames will vary dependent on patient recovery .The anticipated time frame is 1 to 6 months. Maximum follow up is 12 months.Secondary outcomes
1
To assess staff and patient experience of using the Cognishine platform during therapy sessions.
Patients \& therapists will be asked to complete the Mobile Health App Usability Questionnaire (MAUQ)for Interactive Mobile Health Apps used by patients. The questionnaire is designed and validated to evaluate the usability of interactive health apps from the users perspective. The MAUQ questionnaire comprises of 21 questions which cover 3 main usability domains. 1. Ease of use-Navigation, learnability and clarity. 2. Interface and satisfaction-Visual appeal, confidence and overall satisfaction. 3. Usefulness-Perceived value and effectiveness in helping users achieve their health goals. Scoring is via a 7 point Likert scale (1 - strongly disagree, 2 - disagree, 3 - somewhat disagree, 4 - neither agree nor disagree, 5 - somewhat agree, 6 -agree, 7 - strongly agree.),with higher scores indicating greater usability and satisfaction.
Time frame
Patients will be asked to complete this on discharge from hospital. Therapists will be asked to complete the questionnaire one month after starting the study (in the middle of recruitment)2
To generate qualitative data about how to improve the end user experience for therapist to target barriers to implementation
Focus groups composed of therapists who have used the platform will be asked to provide end user information about using the system. This qualitative data will be used to improve the platform.
Time frame
12 month into the study.3
To generate preliminary data on the rehabilitation progress associated with the use of the Cognishine platform.
The Montreal Cognitive Assessment (MoCA) is a standard clinical measurement tool. The tool comprises assessment of visuospatial/executive functions ,naming, memory, attention, language ,abstraction and orientation. The scoring range is 0-30,with higher scores indicating better cognition, scores of \<26 indicating possible cognitive impairment. Scores will be collected from clinical notes at initial assessment and at discharge from rehabilitation therapy.
Time frame
As recovery is highly individualised time frames will vary amongst participants .It is anticipated that the time frame will range from 1 to 6 months.4
To generate preliminary data on the rehabilitation progress associated with the use of the Cognishine platform.
The Oxford Cognitive Screen(OCS) is specifically for stroke patients and reduces visual or language bias. It assesses attention, executive function, memory, language, number processing and praxis. Each domain is scored with results interpreted as impaired or not impaired. Scores from clinical notes will be collected at initial assessment and at discharge from rehabilitation therapy.
Time frame
As recovery is highly individualised time frames will vary amongst participants .It is anticipated that the time frame will range from 1 to 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Liverpool University Hospitals NHS Foundation Trust
Lead sponsor
Israel Innovation Authority
Collaborator
Source ClinicalTrials.gov